Clinical Trial IDNCT02194231
Lead SponsorMario Negri Institute for Pharmacological Research
Principal Investigator
  • Paolo Bidoli
Start Date2013-07-01
Completion Date2019-06-01
Study TypeInterventional
PhasePhase 2
StatusActive, not recruiting

Purpose

The purpose of this study is to determine whether trabectedin is effective in the treatment of malignant pleural mesothelioma (MPM).

Conditions

ConditionInterventionPhase
Malignant Pleural MesotheliomaDrug: TrabectedinPhase 2

Eligibility

AgeGenderAccepts Healthy Volunteers
18 Years and older.AllNo